Roche Holding AG Buying Anadys Pharmaceuticals Inc.

View Comments ()



    Anadys Pharmaceuticals Inc. will go for $230 million according to a Roche statement.

    Swiss drug maker company Roche Holding AG says it is buying San Diego-based Anadys Pharmaceuticals Inc. for $230 million.

    Roche says it will pay $3.70 per share, a premium of more than 250 percent on Anadys's closing price Friday.

    Roche said in a statement Monday that the acquisition would boost its portfolio of drugs to treat hepatitis C.

    Anadys has developed an oral drug called Setrobuvir that is currently being trialed for treatment of chronic hepatitis C infections.

    Record Crowd Making Strides Against Breast Cancer

    [DGO] Record Crowd Making Strides Against Breast Cancer
    As many as 30,000 people took part in Sunday's walk against breast cancer in Balboa Park. The group raised more than $800,000. (Published Monday, Oct. 17, 2011)

    Roche last week reported third-quarter sales of 9.82 billion Swiss francs ($10.98).